Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.
2.

Evaluation of aggressively treated patients with unresectable multiple liver metastases from colorectal cancer.

Miyanari N, Mori T, Takahashi K, Yasuno M.

Dis Colon Rectum. 2002 Nov;45(11):1503-9.

PMID:
12432299
3.

Long-term results of hepatectomy after hepatic arterial infusion chemotherapy for initially unresectable hepatic colorectal metastases.

Fujimoto Y, Akasu T, Yamamoto S, Fujita S, Moriya Y.

J Gastrointest Surg. 2009 Sep;13(9):1643-50. doi: 10.1007/s11605-009-0966-8. Epub 2009 Jul 7.

PMID:
19582514
4.

Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.

Kemeny N, Huang Y, Cohen AM, Shi W, Conti JA, Brennan MF, Bertino JR, Turnbull AD, Sullivan D, Stockman J, Blumgart LH, Fong Y.

N Engl J Med. 1999 Dec 30;341(27):2039-48.

5.

Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin.

Patt YZ, Hoque A, Lozano R, Pozdur R, Chase J, Carrasco H, Chuang V, Delpassand ES, Ellis L, Curley S, Roh M, Jones DV Jr.

J Clin Oncol. 1997 Apr;15(4):1432-8.

PMID:
9193336
6.
9.

Therapeutic efficacy of combination therapy with intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma with portal venous invasion.

Kasai K, Ushio A, Kasai Y, Sawara K, Miyamoto Y, Oikawa K, Kuroda H, Takikawa Y, Suzuki K.

Cancer. 2012 Jul 1;118(13):3302-10. doi: 10.1002/cncr.26648. Epub 2011 Nov 9.

10.

[A long survival case of sigmoid colon cancer patient with initially unresectable hepatic metastases].

Oshima T, Noda M, Tanaka K, Kuno T, Tsukamoto K, Hashimoto A, Gega M, Yagyuu T, Yoshikawa R, Ikeuchi H, Yanagi H, Yamamura T.

Gan To Kagaku Ryoho. 2007 Apr;34(4):631-4. Japanese.

PMID:
17431355
11.

Selective intra-arterial chemotherapy with floxuridine as second- or third-line approach in patients with unresectable colorectal liver metastases.

Samaras P, Breitenstein S, Haile SR, Stenner-Liewen F, Heinrich S, Feilchenfeldt J, Renner C, Knuth A, Pestalozzi BC, Clavien PA.

Ann Surg Oncol. 2011 Jul;18(7):1924-31. doi: 10.1245/s10434-010-1505-2. Epub 2011 Jan 5.

PMID:
21207165
12.

Systemic combination therapy of intravenous continuous 5-fluorouracil and subcutaneous pegylated interferon alfa-2a for advanced hepatocellular carcinoma.

Uchino K, Obi S, Tateishi R, Sato S, Kanda M, Sato T, Arano T, Enooku K, Goto E, Masuzaki R, Nakagawa H, Asaoka Y, Kondo Y, Yamashiki N, Goto T, Shiina S, Omata M, Yoshida H, Koike K.

J Gastroenterol. 2012 Oct;47(10):1152-9. doi: 10.1007/s00535-012-0574-3. Epub 2012 Mar 22.

PMID:
22438097
16.
17.

Folfox4 regimen administered through combined hepatic arterial and systemic infusion for treatment of colorectal cancer with unresectable liver metastases.

Guan M, Chen SC, Ying HY, Zhao L, Li XY, Zhou JF, Shao YJ, Yang XD, Lin Y, Ning XH, Bai CM.

Chin Med J (Engl). 2012 Oct;125(20):3640-5.

18.
19.

Hepatic arterial infusion of 5-fluorouracil for patients with liver metastases from colorectal cancer refractory to standard systemic chemotherapy: a multicenter, retrospective analysis.

Nishiofuku H, Tanaka T, Aramaki T, Boku N, Inaba Y, Sato Y, Matsuoka M, Otsuji T, Arai Y, Kichikawa K.

Clin Colorectal Cancer. 2010 Dec;9(5):305-10. doi: 10.3816/CCC.2010.n.044. Erratum in: Clin Colorectal Cancer. 2011 Mar 1;10(1):7.

PMID:
21208845
20.

Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.

Goéré D, Benhaim L, Bonnet S, Malka D, Faron M, Elias D, Lefèvre JH, Deschamps F, Dromain C, Boige V, Dumont F, De Baere T, Ducreux M.

Ann Surg. 2013 Jan;257(1):114-20. doi: 10.1097/SLA.0b013e31827b9005.

PMID:
23235397
Items per page

Supplemental Content

Write to the Help Desk